Pressure Biosciences Inc
Pressure BioSciences, Inc. develops and sells high pressure technology-based instruments, consumables, and services for life sciences and other industries worldwide. The company's products/services are based on Ultra Shear Technology platform, which turns hydrophobic oil-based supplements, therapeutics, and other active ingredients to water-soluble, bioavailable, oil-in-water nano emulsion formul… Read more
Pressure Biosciences Inc (PBIO) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2024: 0.019x
Based on the latest financial reports, Pressure Biosciences Inc (PBIO) has a cash flow conversion efficiency ratio of 0.019x as of June 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-705.91K) by net assets ($-37.23 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Pressure Biosciences Inc - Cash Flow Conversion Efficiency Trend (2003–2023)
This chart illustrates how Pressure Biosciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Pressure Biosciences Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Pressure Biosciences Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Eckoh Plc
LSE:ECK
|
0.061x |
|
Khiron Life Sciences Corp
PINK:KHRNF
|
-0.186x |
|
CN RESOURCES POWER (CRP.SG)
STU:CRP
|
N/A |
|
NATIONAL INVESTMENT TRUST LIMITED
MSE:NITL
|
N/A |
|
Gamer Pakistan Inc. Common Stock
PINK:GPAK
|
-0.354x |
|
TELB3F
SA:TELB3F
|
N/A |
|
SDX Energy plc
PINK:SDXEF
|
0.856x |
|
KWESST Micro Systems Inc. Warrant
NASDAQ:KWESW
|
-0.237x |
Annual Cash Flow Conversion Efficiency for Pressure Biosciences Inc (2003–2023)
The table below shows the annual cash flow conversion efficiency of Pressure Biosciences Inc from 2003 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $-32.75 Million | $-3.19 Million | 0.097x | -29.00% |
| 2022-12-31 | $-32.69 Million | $-4.48 Million | 0.137x | -37.50% |
| 2021-12-31 | $-22.21 Million | $-4.87 Million | 0.219x | -24.05% |
| 2020-12-31 | $-16.92 Million | $-4.88 Million | 0.289x | -45.01% |
| 2019-12-31 | $-12.06 Million | $-6.33 Million | 0.525x | -43.56% |
| 2018-12-31 | $-6.13 Million | $-5.70 Million | 0.930x | +248.27% |
| 2017-12-31 | $-14.62 Million | $-3.90 Million | 0.267x | -41.18% |
| 2016-12-31 | $-8.38 Million | $-3.81 Million | 0.454x | -5.19% |
| 2015-12-31 | $-7.98 Million | $-3.82 Million | 0.479x | -69.28% |
| 2014-12-31 | $-2.06 Million | $-3.21 Million | 1.559x | +30.93% |
| 2013-12-31 | $-1.97 Million | $-2.34 Million | 1.190x | +31.33% |
| 2004-12-31 | $23.39 Million | $21.20 Million | 0.906x | +1979.48% |
| 2003-12-31 | $10.41 Million | $454.00K | 0.044x | -- |